Veterinary Medicines

BRONCHI-SHIELD, lyophilisate and solvent for suspension for nasal drops for dogs

Authorised
  • Bordetella bronchiseptica, strain 92 B, Live
Download as PDF

Product identification

Medicine name:
BRONCHI-SHIELD
BRONCHI-SHIELD, lyophilisate and solvent for suspension for nasal drops for dogs
Active substance:
  • Bordetella bronchiseptica, strain 92 B, Live
Target species:
  • Dog
Route of administration:
  • Nasal use

Product details

Active substance and strength:
  • Bordetella bronchiseptica, strain 92 B, Live
    2100000.00
    Colony forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for nasal administration
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AE01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Box containing 10 vials of 1 dose of lyophilisate and 10 vials of 1 dose of solvent and 10 cannulae for application

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10387/004/001
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0153/001
Concerned member states:
  • Belgium
  • Germany
  • Hungary
  • Ireland
  • Luxembourg
  • Netherlands
  • United Kingdom (Northern Ireland)